AST Small-Cap Equity Portfolio
Advanced Series Trust
Fund classification
Classified from what the fund holds · as of 2026 Q2
AST Small-Cap Equity Portfolio is an actively managed U.S. equity fund. 28% of AST Small-Cap Equity Portfolio’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 83% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2026 Q2
The investment objective of the Portfolio is to seek long-term capital growth.
The fund invests at least 80% of assets in equity securities of small-capitalization companies, generally those with market capitalizations no larger than the largest company in the Russell 2000 Index. Day-to-day investment decisions are delegated to five subadvisers—Boston Partners Global Investors, Dimensional Fund Advisors, Driehaus Capital Management, Hotchkis and Wiley Capital Management, and TimesSquare Capital Management—whose allocations are determined by the Manager's Strategic Investment Research Group based on market conditions and risk analysis. The fund may hold up to 15% of assets in foreign securities. Because the size threshold for small-cap companies shifts with market conditions, the fund's holdings and focus will change accordingly.
| Share class | Gross | Net | As of |
|---|---|---|---|
| C000005188 | 1.01% | 0.97% | 2025 Q2 |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 62.00% · as of 2026 Q2
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 98.92% |
| Cash & short-term | 24.10% |
Look-through blends 3 underlying funds; 0.669% of NAV was not looked through and stays direct-classified. The blend is as of 2025Q4, one or more quarters before the direct holdings (2026Q2).
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Cash | 23.9% |
| Industrials | 15.3% |
| Financials | 13.0% |
| Health Care | 11.5% |
| 11 smaller | 36.3% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| — | PRUDENTIAL INVESTMENT PORTFOLIOS 9 | 29.54% | — | $624.14M | — |
| — | ISHARES TRUST | 2.06% | $300.45 | $43.44M | 144.6K |
| — | (PIPA070) PGIM Core Government Money Market Fund | 1.33% | — | $28.08M | — |
| — | CREDO TECHNOLOGY GROUP HOLDING LTD | 0.81% | $271.95 | $17.20M | 63.2K |
| ONTO | ONTO INNOVATION INCONTO | 0.76% | $378.45 | $15.99M | 42.3K |
| SITM | SITIME CORPSITM | 0.70% | $745.56 | $14.83M | 19.9K |
| — | JFROG LTD | 0.58% | $90.88 | $12.36M | 136.0K |
| VVV | VALVOLINE INCVVV | 0.57% | $39.54 | $12.10M | 306.1K |
| GRDN | GUARDIAN PHARMACY SERVICES INCGRDN | 0.57% | $41.87 | $12.08M | 288.5K |
| XENE | XENON PHARMACEUTICALS INCXENE | 0.54% | $60.36 | $11.42M | 189.3K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 37.46% of net assets, top 25 44.47%, across 1.9K issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free